Baike Biotech (688276.SH) released its semi-annual performance report, with a net loss attributable to shareholders of 73.57 million yuan, a year-on-year change from profit to loss.

Zhtng Cijng APP News, Baike Biology (688276.SH) disclosed its semi-annual report for 2025, during the reporting period, the company's revenue was 285 million yuan, a year-on-year decrease of 53.93%; the net loss attributable to the parent company was 73.57 million yuan, a year-on-year change from profit to loss; the non-recurring net loss was 82.23 million yuan, a year-on-year change from profit to loss; basic earnings per share was -0.18 yuan.